Loading clinical trials...
Loading clinical trials...
INTENSIVE TREATMENT FOR PERIODONTAL DISEASE: A MODEL OF AND THERAPY OF INFLAMMATORY VASCULAR DYSFUNCTION
The investigators wish to assess whether intensive periodontal therapy will reduce the burden of chronic periodontal disease and will cause regression or prevent progression of atherosclerosis assessed by a surrogate end-point (carotid intima-media thickness) at 24 months compared to control periodontal therapy.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
UCL-Eastman Dental Institute
London, United Kingdom
Start Date
April 16, 2013
Primary Completion Date
March 30, 2020
Completion Date
March 30, 2020
Last Updated
January 25, 2021
190
ACTUAL participants
Intensive Periodontal Treatment
PROCEDURE
Control Periodontal Treatment
PROCEDURE
Lead Sponsor
University College, London
NCT07466966
NCT07297836
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions